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Thiamin(e), also known as vitamin B1, is now known to play a fundamental role in energy metabolism.
Its discovery followed from the original early research on the ‘anti-beriberi factor’ found in rice polish-
ings. After its synthesis in 1936, it led to many years of research to find its action in treating beriberi, a
lethal scourge known for thousands of years, particularly in cultures dependent on rice as a staple. This
paper refers to the previously described symptomatology of beriberi, emphasizing that it differs from
that in pure, experimentally induced thiamine deficiency in human subjects. Emphasis is placed on
some of the more unusual manifestations of thiamine deficiency and its potential role in modern nutri-
tion. Its biochemistry and pathophysiology are discussed and some of the less common conditions asso-
ciated with thiamine deficiency are reviewed. An understanding of the role of thiamine in modern
nutrition is crucial in the rapidly advancing knowledge applicable to Complementary Alternative Medi-
cine. References are given that provide insight into the use of this vitamin in clinical conditions that are
not usually associated with nutritional deficiency. The role of allithiamine and its synthetic derivatives is
discussed. Thiamine plays a vital role in metabolism of glucose. Thus, emphasis is placed on the fact that
ingestion of excessive simple carbohydrates automatically increases the need for this vitamin. This is
referred to as high calorie malnutrition.
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Introduction
Nutritional deficiency is widespread throughout the world.
Most of this is due to economic disadvantage and over-
crowding. In the developing world bad cooking habits may
also account for this problem. Although this form of malnutri-
tion certainly exists in the Unites States, a common form is
associated with moderate affluence and is related to ingestion
of simple carbohydrate in all its different forms. This is
referred to in the text as high calorie malnutrition. Marginal
deficiency of this nature results in typical symptoms that are
sometimes referred to by physicians as functional (1). Because
thiamine is a major factor in the metabolism of glucose, it
has long been known that ingestion of simple carbohydrates,
processed in the body mainly to glucose, automatically
increases the need for dietary thiamine. Thus, high calorie
malnutrition is commonly associated with relative thiamine
deficiency, irrespective of its fortification in food substances.
This review will discuss the biochemistry of thiamine in
animal systems and the various clinical expressions of its diet-
ary deficiency and dependency. It will then describe the clin-
ical uses of the vitamin and its many derivatives that have
resulted in beneficial responses in a variety of diseases in
man and animals. Its place in nutrient-based Complementary
Alternative Medicine is emphasized.
Historical Facts
In 1965, a Vitamin B Research Committee in Japan provided
detailed information on the history of the scourge of beriberi,
now known to be associated with deficiency of thiamine (2).
The disease has been known since antiquity and its original
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The mortality per 100 of the Japanese population in the 20th
century began to decline from 30 in the 1920s to 0.5 in 1969
after its thiamine deficient etiology was discovered.
In 1965, the morbidity from beriberi was not accurately
known. A study of 375 patients seen in Tokyo Medical and
Dental College Hospital revealed that 109 (29%) had at least
two of the major beriberi signs of hyporeflexia, hypesthesia,
edema, lowered diastolic pressure and tenderness by grasping
the calf muscles.
A curious phenomenon observed was that death from the
disease had a regular seasonal variation, with the peak in
August and September, found every year between 1899 and
1938 when records were kept. There was also increased mor-
bidity in working areas where humidity was high. The incid-
ence of infantile beriberi followed the same pattern, and was
higher in males than in females by a ratio of 1.76 : 1.0.
That beriberi was closely related to food was first pointed
out by Takaki, a Japanese navy surgeon. In 1882, a naval ves-
sel from Japan returned after 272 days with 61% of its crew
affected with beriberi. In 1884, Takaki loaded another warship
with dry milk and meat. After a voyage of 287 days, only 14
of the crew had succumbed to the disease. Takaki concluded
that the disease was caused by a lack of nitrogenous food in
association with excessive intake of non-nitrogenous food.
In 1890, Eijkman accidentally found that fowls, when fed
polished rice, died soon from paralysis and that the peripheral
nerves revealed histological changes analogous to those seen
in human beriberi. In 1901, Grujns found that starch feeding
had the capacity to produce the same pattern in fowls.
It gradually became evident that polished rice ingestion
caused beriberi and that rice bran germ, barley and red beans,
when taken together with polished rice, would prevent the dis-
ease. Funk and Cooper eventually isolated a substance from
rice polishing and called it ‘Vitamine’. This early research
eventually led to the discovery of the active principle and it
was named thiamine.
Beriberi was the first disorder in which the term ‘deficiency
disease’ was used. Polyneuritis in fowls restricted to a diet of
polished rice appeared to be similar to the polyneuritis in beri-
beri victims. This prompted Eijkman in the Dutch East Indies
to study the problem. He showed that the polyneuritis in fowls
could be prevented by diet and reported the results of his stud-
ies in 1896–97. The ‘anti-beriberi’ substance was crystallized
from rice polishings by Jansen and Donath in 1926 (3). The
structure and synthesis of thiamine was reported by Williams
(4), and the ground-breaking work on its biochemical action
was studied by Peters (5).
Biochemistry
Thiamine
In various publications, it is spelled with and without the ‘e’.
The ‘e’ was dropped when it was found that it was not an
amine. The word is used here with an ‘e’ is used here since it
appears still to be more commonly used. It consists of a pyri-
midine ring (2,5-dimethyl-6-aminopyrimidine) and a thiazo-
lium ring (4-methyl-5-hydroxy ethyl thiazole) joined by a
methylene bridge.
Natural Sources
Thiamine is present in lean pork and other meats, wheat germ,
liver and other organ meats, poultry,eggs, fish, beans and peas,
nuts, and whole grains. Dairy products, fruit and vegetables are
not good sources. The RDA is 0.5 mg per 1000 kcal, adequate
for a healthy individual consuming a healthy diet. Consider-
able losses occur during cooking or other heat-processing of
food. Polyphenolic compounds in coffee and tea can inactivate
thiamine so that heavy use of these beverages could comprom-
ise thiamine nutrition (6).
Thiamine monophosphate
A review of the thiamine literature revealed that little or noth-
ing is known about whether there is a specific biochemical role
of thiamine monophosphate (TMP) other than it being a step
from free thiamine to the intracellular synthesis of thiamine
diphosphate and triphosphate. It may be analogous to the step-
wise phosphorylation of adenosine.
Thiamine pyrophosphate (diphosphate)
Although the basic chemistry of thiamine is now fairly well
known, there is a great deal of information still missing. It
can be stated that it is an incredibly active molecule and plays
a part in many different aspects of energy metabolism.
Not long after thiamine was recognized as a nutritional
requirement for many forms of life, it was found that its pyro-
phosphate ester, thiamine diphosphate (TPP) was a cofactor
for enzymatic reactions that cleave alpha-keto acids. It is
now well known that TPP activates decarboxylation of pyr-
uvate in the pyruvate dehydrogenase complex. This complex
is a group of enzymes and cofactors that form acetyl CoA
that condenses with oxaloacetate to form citrate, the first com-
ponent of the citric acid cycle. Since pyruvate is derived from
glucose via the Embden–Meyerhof pathway, it should be
emphasized that the energy drive from oxidation of glucose
is highly dependent upon TPP. It is also a cofactor in the
decarboxylating component of alpha-ketoglutarate dehydro-
genase, an important link in the citric acid cycle.
A third enzyme complex that requires TPP as a cofactor is
the macromolecular aggregation that decarboxylates the keto
acids derived from leucine, isoleucine and valine, the branched
chain amino acids. The fourth important enzyme requiring
TPP is transketolase, an enzyme that occurs twice in the
pentose shunt. The functions of this pathway are to provide
pentose phosphate for nucleotide synthesis and to supply
reduced NADP for various synthetic pathways. Activity of
this enzyme has been used for many years as the best func-
tional test for evidence of thiamine deficiency (7). Since
the pentose shunt occurs in erythrocytes, these cells become
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detecting deficiency.
Thiamine Triphosphate
As early as 1938, Minz (8) first suggested a relationship
between thiamine and nervous excitation when he observed
that thiamine was released into the bathing medium when
the pneumogastric nerve, taken from an ox, was stimulated.
Cooper and Pincus (9) reviewed the evidence that there was
a possibility that thiamine has a neurophysiological function
that is distinct from its activity as a coenzyme. They reported
that thiamine appears to be uniformly distributed throughout
the nervous system and appears to be highly localized in
membrane structures. More recently, the distribution of
thiamine was studied in rats (10). After intracerebroventricular
injection of labeled thiamine the distribution of its radioactive
esters was found to be as follows: thiamine, 8–12%; TMP,
12–14%; TPP, 72–74%; and thiamine triphosphate (TTP),
2–3%.
Cooper and Pincus (9) had reported that they, and other
investigators, had confirmed that nerve stimulation in experi-
mental animal systems resulted in decline of the level of TPP
and TTP in the preparation. The released compounds were in
the form of TMP and free thiamine. This phenomenon made
it difficult to interpret the function of the vitamin in nerve con-
duction. Bettendorff et al. (11) discussed the physiological sig-
nificance of TTP in the main electric organ of Electrophous
electricus that is particularly rich in TTP, representing 87%
of the total thiamine content of this tissue. The real substrate
of TTP phosphatase, they said, is probably a 1 : 1 complex of
Mg
2þ and TTP. Incubation of rat brain homogenates with
thiamine and TPP leads to synthesis of TTP (12) and further
study suggested that TTP is an activator of chloride channels
having a large unit conductance (13). In mammalian tissues
TTP concentrations are regulated by a specific thiamine tri-
phosphatase (14). The role of TTP is, however, incompletely
known at the present time.
Thiamine Transporter
The SLC gene family of solute carriers is a family of three
transporter proteins with significant structural similarity, trans-
porting substrates with different structure and ionic charge.
SLC19A1 mediates the transport of reduced folate and its
analogs and SLC19A2 mediates the transport of thiamine.
SLC19A3 is also capable of transporting thiamine (15,16).
Thiamine Deficiency Disease
The classical syndrome caused primarily by thiamine defi-
ciency in humans is beriberi, in which the benefit of thiamine
in prevention and treatment is uncontested (17,18). In older
texts it has been divided into categories known as ‘wet’, ‘dry’,
‘childhood’, ‘infantile’ and Wernicke–Korsakoff syndrome.
More modern knowledge recognizes that the symptoms and
signs may or may not be associated with edema and vary
according to the age of the patient. Its presentation also
depends on the association with other vitamin deficiencies
and the ingestion of empty calories, particularly in the form
of simple carbohydrate. Description of symptoms and signs
associated with the various aspects of the disease have
been thoroughly reviewed many years ago (19) and need not
be reiterated in this review. Some of the lesser known and
uncommon manifestations of thiamine deficiency are
discussed later in the text. It is to be emphasized that they are
based on only a few reported case studies and that there are
insufficient data in the literature to support these associations
conclusively.
Although the vitamin has been known since the 1930s and
experimental work has been performed in both animals and
man, the overall mechanisms resulting from its deficiency
are still not completely understood. Platt (20), one of the earli-
est investigators of beriberi stated that a conference in Prin-
ceton had stressed that thiamine deficiency (TD) and beriberi
were not synonymous terms, perhaps emphasizing the import-
ance of the inter-relations of other nutrients with thiamine. The
clinical features of beriberi have long been largely forgotten in
modern medicine since it has been assumed that the classic
deficiency diseases do not occur in developed societies. It is,
however, important to state that dysfunction in the autonomic
system was a prominent part of the clinical expression of
beriberi (21) and reversible autonomic dysfunction, associated
with evidence of high calorie malnutrition, has been reported
in recent times in the United States (22,23). Sweating, tachy-
cardia, dermographia, wide unstable pulse pressure, attention
deficit and other symptoms of autonomic dysfunction in
children have been reported as functional dysautonomia (24).
Limited data are available on the relation between thiamine
requirements and the intake of carbohydrates. A study has
been reported that investigated the influence of stepwise
increases of carbohydrate intake on the status of thiamine
in healthy volunteers under isocaloric conditions (25). An
increase of dietary carbohydrate intake caused a decrease of
plasma and urine levels of thiamine without affecting enzyme
activities.
Glyoxals are reactive alpha-oxoaldehydes that are formed
endogenously from sugars, the levels of which are increased
in various pathological conditions associated with hyper-
glycemia and thiamine deficiency. A study found that low con-
centrations of glyoxal markedly increased the susceptibility
of hepatocyte glutathione (GSH) to oxidation by hydrogen per-
oxide. It increased cytotoxicity by compromising the cellular
antioxidant enzyme system. At higher concentrations it was
cytotoxic towards hepatocytes, attributed to GSH depletion,
oxidative stress and mitochondrial toxicity. Glyoxal toxicity
was prevented by increasing its metabolic breakdown with
thiamine or NADP(P)H generators. Toxicity was increased
in GSH or thiamine-deficient hepatocytes (26). These authors
suggested that Western diets, frequently poor in thiamine and
high in sugars, could result in increased levels of endogenous
glyoxals that may lead to predisposition to advanced glycation
end product-related pathology and neoplasia.
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possible to state that high simple carbohydrate malnutrition
can cause symptoms of early beriberi. Since beriberi conjures
up an unacceptable concept in the mind of many modern
physicians it is probable that it would not be considered in dif-
ferential diagnosis. It is very likely that many of the poorly
understood symptomatology seen today that responds to nutri-
ent therapy is caused by a mixture of marginal classic
nutritional diseases, including beriberi, pellagra and scurvy.
In our experience it is certainly true that symptoms arising
from autonomic dysfunction are usually reversible by nutri-
tional therapy. These symptoms are not infrequently associ-
ated with mitral valve prolapse, also associated with
dysautonomia (27).
Lonsdale and co-workers (1,28) have published evidence of
TD in modern clinical practice due to high calorie, simple car-
bohydrate malnutrition. The symptoms generated by this kind
of malnutrition fall into the range of traditionally diagnosed
functional disease. Generally speaking, the deficiency is mar-
ginal and this might be defined as a thiamine pyrophosphate
effect (TPPE) of between 15 and 25% in measuring erythro-
cyte transketolase (17). A patient receiving intravenous hyper-
alimentation contracted Wernicke’s encephalopathy. Although
there is a profuse literature on the association of alcoholism
with TD and Wernicke’s encephalopathy, the encephalopathy
in this patient had occurred in spite of the fact that she had
been receiving 25 mg of thiamine in the intravenous solution
(29). Although alcohol-associated Wernicke–Korsakov syn-
drome is the most frequently encountered manifestation of
TD in Western culture, it is also seen without alcoholism.
Poor nutrition, gastrointestinal disease and AIDS can cause
the syndrome. The pathology is restricted to the central nerv-
ous system (CNS) (30). TD has been reported in association
with parenteral nutrition in 11 neonates (31), suggesting that
the lesion is etiologically associated with an inability to oxid-
ize the high calorie input.
Necropsy studies have suggested that TD is underdiagnosed
in life because the classical clinical presentations are either
uncommon or unrecognized. Marginal TD was found in 31%
and definite deficiency in 17% of 36 non-demented, commu-
nity-dwelling patients admitted to an acute geriatric unit (32).
There is no doubt that severe TD is lethal but marginal defi-
ciency can give rise to symptoms that are commonly mis-
taken for functional disease (1,28). A very early experiment
in human subjects showed that marginal deficiency produced
a multitude of symptoms that might, under ordinary clinical
conditions, be regarded as functional in nature. The symptoms
disappeared quickly when a thiamine sufficient diet was
restored (33). Animal studies have shown that rats develop
aggressive reflex behavior when marginal thiamine deficiency
is induced experimentally (34,35). A live mouse, introduced to
the cage where a thiamine deficient rat was housed, would be
killed, but thereafter ignored and not consumed. Persistent
erection suggested increased autonomic activity. It is possible
that this might be a clue to poorly understood aggressive
human behavior.
TD has been reported in refractory heart failure (36) and
has occurred in epidemic form in Cuba involving 50862
(461.4 per 100000) people. Lesions included peripheral
neuropathy, retrobulbar optic neuropathy, sensory and dys-
autonomic peripheral neuropathy, sensorineural deafness,
dysphonia, dysphagia and spastic paraparesis (37,38). TD
ataxia (39), post-gastrectomy polyneuropathy (40) and revers-
ible autonomic neuropathy involving bladder dysfunction (41)
have been described.
Pathophysiology of Thiamine Deficiency
The pathophysiology is complex and only partly understood.
A conference in 1982 was published that reviewed the existing
knowledge of the vitamin at that time (42). In pyrithiamine-
induced thiamine deficiency in animal studies, the net levels
of phosphocreatine in the lateral vestibular nucleus and other
nuclei of brain were increased selectively. The author sugges-
ted that this was possibly due to under utilization (43). Altera-
tion was found in the cerebellar high affinity uptake system
for serotonin, aspartate and glutamate in rats with chronic
or acute TD (44). It was hypothesized that this was related
to deterioration of many membranous systems. Gibson et al.
(45) concluded that several lines of reasoning implicate the
cholinergic system in the pathophysiology of TD.
Experiments in DBA/J2 mice supported this hypothesis (46).
In spontaneously remitting audiogenic seizures in neonates
of this inbred strain, known to be cholinergically generated,
the seizures were more severe and the spontaneous remission
delayed by pretreatment with thiamine tetrahydrofurfuryl
disulfide (TTFD). Meador et al. (47) found evidence for a
central cholinergic effect of thiamine by studying its action
on the cognitive deficits induced by scopolamine in healthy
young adults and thiamine treatment resulted in a mildly
beneficial effect in some patients with Alzheimer’s disease
(AD) (48,49).
Levels of free thiamine and its esters, TMP and TPP and
activities of the three TDP-metabolizing enzymes, thiamine
pyrophosphokinase, thiamine diphosphatase and thiamine
triphosphatase, were measured in autopsied cerebral cortex
of 18 patients with AD, compared with 20 matched controls
(50). In the AD group, mean levels of free thiamine and
TMP were normal, whereas levels of TDP were reduced by
18–21%. Activities of the TDP-metabolizing enzymes were
normal. The authors suggested that the TDP decrease could
be explained by a cerebral cortical deficiency of ATP in AD,
since this is needed for TDP synthesis. This slight decrease
in AD brain might explain the modest improvement in cognit-
ive status in some AD patients when treated with thiamine.
Central Sleep Apnea and Thiamine Metabolism
Three of six siblings presented with sleep apnea between the
ages of 18 and 26 months. Twin females first had irregular
respiration and episodes of apnea. Twin A succumbed to an
apneic episode while asleep and the diagnosis of sleep apnea
was made in Twin B at a sleep clinic. She died in an apneic
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fashion. A fourth, unrelated child was reported with sleep
apnea at the age of 7 weeks and died at 31 months. Lesions
were confined to the respiratory centers of the lower brain
stem (51). The relationship with thiamine metabolism was
indicated by the fact that the fourth child, and family members,
reported in this publication tested positive for a TTP inhi-
bitor substance found in their urine (52). The detection of
this inhibitor substance, though never identified, was thought
to be a specific marker for the diagnosis of Leigh’s disease
(subacute necrotizing encephalomyelopathy) (53).
Cooper had used the detection of this substance as a dia-
gnostic test for Leigh’s disease. We had, however, come to
the conclusion that the test was important in a variety of
patients with neurological symptoms whose urines were sent
to Cooper’s laboratory (D. Lonsdale, unpublished data). This
we had found to be a potentially important indication for
thiamine administration since many of these patients, who
did not have Leigh’s disease, responded clinically to thiamine
supplementation. The test was performed exclusively in
Cooper’s laboratory and has never been used, to our know-
ledge, since Cooper abandoned this research years ago. We
can only assume that it demonstrated, in some important
way, the activity of TTP in the CNS. To date, there is no other
way of detecting TTP deficiency in the laboratory.
Sudden Infant Death
Familial sleep apnea (51) and the association with the TTP
inhibitor supports the long considered concept that TD pro-
duces a central effect, particularly in the rapidly growing brain
of infants and children. The lesions were confined to the brain
stem and this is not the autopsy picture of Leigh’s disease, the
condition most associated with TTP metabolism in brain. It has
long been our contention that sudden infant death syndrome
(SIDS) is due to brainstem dysfunction related to hypo-
oxidative metabolism (54). There appears to be ample reason
for considering thiamine to play an active role in maintaining
the physiology of brainstem activity where the complex mech-
anism that governs automatic respiration is situated. Fehily
(55) was the first investigator to find that TD was responsible
for sudden death in infants. Her communication indicated
that high calorie malnutrition, in the shape of milled rice eaten
by the breast feeding mothers of these infants was responsible.
This was further explored in more recent years by Read and co-
workers in Sydney, Australia (56) and Lonsdale et al. (57–61).
Barker and Jordan (62) found that thiamine phosphate ester
gradients along the phrenic nerve and recurrent laryngeal
nerve in SIDS infants revealed axonal thiamine depletion with
net efflux of  70% compared with fire death controls and
other SIDS nerves. The ester most deficient in the SIDS infants
was TTP. Some recent publications discuss the abnormal
baroreflex mechanisms (63) and the effect of hypoxia (64) in
central hypoventilation syndrome, but the underlying etiology
is described as congenital and no biochemical research was
associated with their discussions.
Thiamine Deficiency Related to Other Nutrients
Although the full extent of nutrient interdependency is far
from fully known, there is certainly evidence that thiamine
activity is related to other non-caloric nutrients. For example,
calcium and magnesium deficiency affects thiamine distribu-
tion in rat liver (65) and magnesium has a particularly import-
ant role since it is reported to aggravate thiamine deficiency
(66). Administration of magnesium, high energy phosphates,
piracetam and thiamine affected erythrocyte transketolase
activity (67). A physiological concentration of magnesium
can be shown to regulate TPP binding to the thiA riboswitch
RNA (68).
Thiamine Dependency
A child with intermittent episodes of cerebellar ataxia (69)
proved to be the first case of thiamine dependency in the
decarboxylating component of pyruvate dehydrogenase defi-
ciency (70). It is important to emphasize that individual epis-
odes of ataxia occurred in this child in association with some
stress factor. This could be a simple viral or bacterial infection,
a relatively mild head injury or an inoculation. Even sudden
exposure to air conditioning could set off symptoms in this
patient. The regular dose of thiamine that he required was
600 mg and this needed to be doubled if a stress factor became
implicated. Incidents of this nature that are described here as
‘stress factors’ are usually found to be important in marginal
metabolic situations where cofactor dependency exists.
Thiamine responsive pyruvate dehydrogenase deficiency has
been reported more recently (71). Infection was an initiating
mechanism in intermittent branched chain ketoaciduria
(maple syrup urine disease) (72) and this disease has been
found in some cases to be responsive to thiamine, the cofactor
for the enzyme that decarboxylates the branched chain keto
acids (73).
An extraordinary case of thiamine dependency came to my
attention. A 6-week-old girl was referred with the possibility
of her physical appearance being associated with a chromo-
somal syndrome. Chromosome analysis was normal but there
was laboratory evidence that there was thiamine deficiency
from an abnormal transketolase. Thiamine supplementation
produced an immediate clinical improvement. As she grew,
however, her mother found independently that she had to
increase the thiamine dose that eventually rose to as high as
7 g a day. Although never completely normal, she graduated
from high school where she had been a member of the march-
ing band. She died at the age of 27 years from toxic shock asso-
ciated with an infection. The biochemical lesion was never
studied (D. Lonsdale, unpublished data).
There seems to be little doubt that there are recurrent
illnesses that are interpreted wrongly because of a general
failure to recognize an underlying metabolic process. For
example, not many physicians might think that recurrent feb-
rile lymphadenopathy would be anything but the symptoms
generated by infection. Two patients with this clinical pre-
sentation whose health was completely restored by treatment
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Both children exhibited defective thiamine metabolism and
the extended requirement of large doses of this vitamin
suggested some form of dependency. This suggests that the
brain initiating mechanisms of defense in these children were
abnormally sensitive to possibly unknown or unrecognized
‘stress factors’ that could obviously include microorganisms.
Since viral infections are seldom elucidated in clinical
practice, it has become an acceptable explanation for such
illnesses. To make it worse, an antibiotic is often prescribed
on the assumption that a bacterial phase may follow what is
considered to be a viral infection initially.
Thiamine Transporter Disease
The SLC19 gene family of solute carriers have been described
(15,16). The molecular family of the blood–brain barrier
(BBB) choline tranporter may be elucidated in vitro by its
interaction with physiologic thiamine levels, and two cationic
transporters at the BBB may be responsible for thiamine brain
uptake (75). Thiamine responsive megaloblastic anemia
(TRMA) syndrome is an autosomal recessive disorder with
features that include megaloblastic anemia, mild thrombo-
cytopenia, leucopenia, sensorineural deafness and diabetes
mellitus (76). Mutations in the SLC19A2 gene encoding a
high-affinity thiamine transporter protein THTR-1 are
responsible for the clinical features associated with TRMA
syndrome (77).
A mouse model of the TRMA syndrome, lacking functional
SLC19A2, has been generated and unexpectedly found to have
a male-specific sterility phenotype. Injection of high-dose
thiamine was effective in reversing the spermatogenic failure,
suggesting that the absence of the thiamine carrier could
be overcome by diffusion-mediated transport at supranormal
thiamine concentrations (78). These findings suggest an unex-
pected and critical role for thiamine transport and metabolism
in spermatogenesis.
Three TRMA patients have been reported with heart rhythm
abnormalities and structural cardiac anomalies (79). The
authors suggest that the metabolic defect of TRMA may shed
light on the role of thiamine in common cardiac abnormalities,
possibly leading to considering routine thiamine supplementa-
tion in commonly observed cardiac failure where an etiology is
not clear. Thiamine is in free form in the intestinal lumen and
in very low concentrations.Absorption takes place primarily in
the proximal part of the small intestine by means of a dual
mechanism, which is saturable at low physiological concentra-
tion and diffusive at higher. The saturable component is miss-
ing in patients with TRMA syndrome, producing a general
disturbance of thiamine transport (80).
Laboratory Studies
Platt (20) reported that all his patients with the mild and
subacute forms of beriberi had creatinuria. He was unable to
determine whether this was a direct result from the thiamine
deficiency or whether it was caused by protein calorie defi-
ciency secondary to anorexia that was a constant feature of
the disease. In the early days of investigation of the relation-
ship of TD with beriberi, anorexia was used as an important
clinical marker of severity of the disease. Return of appetite
heralded clinical improvement (Fig. 1).
For this reason, we performed an experiment in rats to try
to determine whether creatinuria was due solely to TD (81).
Animals that were in a state of partial starvation, consuming
a thiamine sufficient diet in an amount equivalent to that
Figure 1. Synthesis, transport and utilization of creatinine and its excretory relationship with creatinine.
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Increase in creatinuria occurred in both groups as compared
with a control group. The increase in creatinuria occurred
much earlier in the TD group and was much greater than in
the starved animals. We concluded that creatinuria did indeed
occur in protein calorie deficiency but that TD had a marked
effect on this increase. It suggested cell membrane related
phenomena as the underlying cause. It is mindful of the greater
degree of creatinuria observed in calorically starved T3
injected rats than in calorically sufficient animals injected
with T3 (81).
By examining urine from patients in two 12 h aliquots, we
found that creatine, creatinine and uric acid all followed a
pattern of high day/low night concentrations that suggested
their response to circadian rhythm (81). Several patients
were reported where treatment with thiamine resulted in
decreased urinary concentration of creatine and uric acid,
while concomitant concentration of creatinine increased (81).
This was commensurate with their clinical improvement.
This kind of simple test, though by no means specific in indic-
ating TD, was found to indicate biochemical recovery from
vitamin therapy, usually accompanied by clinical improve-
ment. Alternating high day and low night concentrations of
urinary alanine and pyruvate rose to a peak during an episode
of cerebellar ataxia in a child and returned gradually to a nor-
mal level as the ataxia slowly and spontaneously improved
over an 8 day period. As noted above, this proved to be the
first example of thiamine dependency due to compromise of
pyruvate decarboxylation (69,70). The mechanism for the
day/night alternation of urinary metabolites, though unknown,
suggested that circadian rhythm might be involved (81).
The most important laboratory study for TD is measurement
of the activity of the enzyme transketolase. Erythrocytes can
be used and the test can be made readily available in any com-
mercial laboratory (1,82–84). It has also been reported that
transketolase appears to diminish the binding of TPP to the
apoenzyme in some patients with Wernicke–Korsakoff syn-
drome (85). More recently, it has been shown that thiamine
metabolism is linked to the pathology in a number of brain dis-
eases and that it is an important indicator of oxidative stress
(86). Abnormal transketolase activity has been reported in
some autistic children (87).The cornea contains a particularly
high transketolase concentration, consistent with the proposal
that pentose phosphate pathway activity has a role in the
removal of light-generated radicals (88). Abnormal erythro-
cyte transketolase activity demonstrated that thiamine defi-
ciency was found in a high percentage of HIV-infected
patients, not only when in advanced stages but in clinically
asymptomatic patients (89).
Neurological disorders in lead intoxicated animals, though
not specified by the authors, have been observed in thiamine
deficient animals (90). Three-week-old Wistar rats were trea-
ted with lead or lead plus thiamine and compared with a thiam-
ine deficient group. Thiamine contents and transketolase
activity in the brain were significantly lowered by lead intox-
ication and thiamine deficiency. In both cases, thresholds of
electroshock stimulated seizures were decreased. Thiamine
supplementation reversed these signs and decreased the brain
lead concentration in the lead treated group (90). Olkowski
et al. (91) studied the relative efficacy of thiamine and/or cal-
cium disodium EDTA administration on lead excretion in
lead-loaded sheep. They concluded that thiamine enhances
elimination of lead from the body and that this feature may
be beneficial in chelation therapy. Kim et al. (92) studied the
effects of thiamine on the whole body retention of lead in
CD-1 mice and concluded that thiamine administration may
have therapeutic application for the treatment of lead poison-
ing. This may be important in treatment of human disease
caused by intoxication with SH reactive metals and suggests
that further study is required (87).
Thiaminase
In 1941, Fujita (93), while engaged in determining the vitamin
content of Japanese foodstuffs, found that the thiamine content
of some shellfish and crustacea was zero and any added thiam-
ine could not be recovered. He found that the thiamine was
being destroyed by an enzyme that he named aneurinase. He
traced the discovery of two enzymes that destroyed thiamine.
Thiaminase I (EC 2.5.1.2) splits the pyrimidine from the thia-
zolium ring at the methylene bridge and attaches a base com-
pound to the pyrimidine ring to form an analog inhibitor of
thiamine metabolism. The enzyme is produced by Clostridium
thiaminolyticum, an anerobic bacterium found in human small
intestine. It isalso produced by Bacillus thiaminolyticus,that is
aerobic and found in the colon. Bacillus aneurinolyticus is
also aerobic, found in the colon and produces thiaminase II
(EC3.5.99.2). This enyme functions in the same way as thiam-
inase I without the attachment of a base compound. Edwin and
Gwyneth (94) wrote that thiaminase I was found in the ruminal
contents of animals affected by cerebrocortical necrosis.
Thiaminases may have a limited part to play in human disease.
A case was reported by Murata in 1965 (95). The patient in
question had beriberi and potent thiaminase activity was found
in the feces. This was then found to be produced by a bac-
terium in the patient’s feces and was termed ‘Thiaminase dis-
ease’. Seasonal ataxia and impaired consciousness occurs in
Nigerians, apparently in epidemic form. A recent study found
activity of thiaminase I extracted from the pupae of an African
silkworm that is consumed as a source of protein (96). This
was the first report of an insect thiaminase and was considered
to be the putative cause of the seasonal outbreaks of this
disease.
Thiamine Derivatives
Many thiamine derivatives have been synthesized after the dis-
covery of allithiamine (97) (Figs 2 and 3) Most of the original
studies were performed in Japan and the details were published
in 1965 (98). Although a series of S-acyl derivatives were
studied, these investigators found that the disulfides had the
best therapeutic effect (99). It was noted that S-acyl derivatives
are devoid of the preventive effect against trichloroethylene,
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investigation of thiamine propyl disulfide, one of the early
disulfide derivatives. These early investigators ascribed this
failure to prevent toxicity to the absence of the S–S bond.
The disulfides are easily reduced to thiamine in the presence
of cystine or glutathione while the S-acyl derivatives require
enzymatic reduction in liver or kidney.
The lipophilic derivative known as benfotiamine (S-
benzoylthiamine monophosphate, BTMP) has recently
received attention and is reported to have clinical benefit in
the complications of diabetes (100–103). TTFD is the most
modern synthetic disulfide derivative and this has been studied
extensively in a variety of clinical conditions (61,87,104–107).
What may be of some importance is the disposal of the
prosthetic group that is evolved from any of these derivatives.
The mercaptan derived from the disulfide derivatives, that
is left outside the cell membrane as the complete molecule
is hydrolyzed to deliver thiamine into the cell, has been
well studied for its metabolic breakdown (108–112). Its
pharmaceutical effect, if any, is unknown.
A poorly known therapeutic use of TTFD may well be in
its anti-inflammatory effect. Intraperitoneally administered
TTFD and thiamine propyl disulfide (TPD) showed a strong
inhibitory effect in carrageenin induced rat paw edema (113).
This effect was potentially supported by finding that TTFD
reversed the gradual increase in coronary blood flow in the
heart–lung preparation of a dog by inhibiting the arachidonic
acid cascade-line activation (114).
An open trial with TTFD was performed on 44 patients with
polyneuropathy. Thirty-four patients showed improvement
of motor function and some restoration of sensory function.
Of 18 patients re-examined electrophysiologically 3 months
later, 6 showed remarkable improvement. No side effects
were observed (115).
Beriberi cardiomyopathy is a well known entity in rice con-
suming cultures. Three patients were reported with beriberi
who presented with different clinical manifestations. The
cardiac symptoms responded dramatically to TTFD and there
were some improvements in their polyneuropathy measured
by somatosensory evoked potentials. These authors stress
that the mortality of untreated cardiovascular beriberi is high.
In view of the harmless nature of the treatment, they suggested
that routine administration of TTFD should be given to all
patients in whom heart failure is present without clear evid-
ence of cause (116). In a 12 week open trial, mildly impaired Figure 2. Synthetic allithiamine homologs.
Figure 3. S-acyl-thiamine derivatives.
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ment. No adverse reactions were observed (117).
A test known as the intravenous olfaction test with TPD is
a simple procedure widely used in Japan (118). An olfactory
stimulus is provided by intravenous injection of TPD and
the subject smells n-propyl mercaptan, the prosthetic group
derived from hydrolysis. This is discharged from blood
into the alveoli and expired. The authors recorded electro-
encephalographic changes during the intravenous olfactory
stimulation and found alpha-2 and beta-2 waves to be activated
over the frontal and temporal regions. The EEGs returned
to pre-stimulus levels after disappearance of the olfactory
sensation.
It was found that an open thiazole ring thiol form of thiamine
(unspecified) released nitric oxide from S-nitrosoglutathione
(119), a potentially important factor in the therapy of vas-
culopathy. This might also explain the benefit of thiamine
derivatives in the microangiopathy of diabetes (100–103) and
certainly deserves further research and clinical trials.
Conclusion and Hypothesis
The use of thiamine, and its disulfide derivatives in particular,
is muchneglected in Western medicine. The interest in this vit-
amin arose in Japan when it was discovered that it had a major
part to play in preventing and treating beriberi, a scourge that
had affected Eastern cultures for thousands of years. The nutri-
tional diseases have been long associated with poverty and
starvation. Starvation, however, represents loss of both calorie
yielding and vitamin/mineral containing food and is usually a
slow attrition to death. If the calories are maintained without
the vitamin/mineral content, also known as empty calories,
the disease outcome is very different. Modern Western diet,
particularly in children and adolescents, is loaded with simple
carbohydrates. In our own clinical experience vitamin defi-
ciency is undoubtedly extremely widespread and thiamine fig-
ures very high in this deficiency because of its biochemical
association with glucose metabolism (1,18,24,25,28,54,83,84).
Because of vitamin fortification of many foods and the relative
affluence of our present culture we are not ready to consider
that obscure symptoms, particularly those that are generally
termed functional, are of dietary origin. They are very fre-
quently the direct result of years of high calorie diet and treat-
ment with large doses of the appropriate vitamin/mineral
supplementation is mandatory. Physiological doses have no
effect since the enzyme/cofactor bonding appears to be dam-
aged or partially atrophied. Thus, physicians often become
disenchanted when they treat a patient with low-dose supple-
mentation and see no benefit. The RDA of thiamine is
1–1.5 mg per day, but only in a biochemically healthy
individual, and many physicians are under the impression
that this kind of vitamin deficiency, if it occurs at all, is easily
and quickly treated. As in the association recorded in this
review in the treatment of beriberi, it took very large doses
of thiamine for months and there was often only partial
recovery and sometimes none at all (20).
It is hypothesized that some crimes and nutritional
deficiency are related and that thiamine, because of its associ-
ation with high carbohydrate intake, including alcohol, may
play a significant role. This is certainly not a new concept.
Nutritional deficiency and its association with crime has been
shown to be an extremely important relationship (120–123).
Although the explanation for this has never been attempted,
it is suggested that perhaps primitive reflex activity in the
limbic system might occur under extreme stress when the
supervisory action of the cognitive brain is overwhelmed.
It is worth reminding ourselves that the body is a self-healing
‘machine’ and all it requires is an appropriate amount of
energy to fulfill this amazing role. Vitamins and minerals are
to the body as the simple spark plug is to the automobile.
The oxidative process requires oxygen, fuel and catalysts and
the vitamin/mineral complex is a magnificent effect of
millions of years of evolution. We ignore it at our peril.
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